Publications | Page 174 | Pathology & Laboratory Medicine

Filter By Faculty

Filter by Principal Investigator

Cascione L, Rinaldi A, Chiappella A, Kwee I, Ciccone G, Altenbuchinger M, et al. Diffuse large B cell lymphoma cell of origin by digital expression profiling in the REAL07 Phase 1-2 study. Br J Haematol. 2018;182(3):453-456.

Wang J, Yao Z, Jonsson P, Allen AN, Qin AC, Uddin S, et al. A Secondary Mutation in Confers Resistance to RAF Inhibition in a -Mutant Brain Tumor. Cancer Discov. 2018;8(9):1130-1141.

Magro CM, Daniels BH, A Crowson N. Drug induced pseudolymphoma. Semin Diagn Pathol. 2018;35(4):247-259.

van Rhee F, Voorhees P, Dispenzieri A, Fossa A, Srkalovic G, Ide M, et al. International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease. Blood. 2018;132(20):2115-2124.

Soshnev AA, Josefowicz SZ, C Allis D. Greater Than the Sum of Parts: Complexity of the Dynamic Epigenome. Mol Cell. 2018;69(3):533.

Hawkins PA, Law CS, Metcalf BJ, Chochua S, Jackson DM, Westblade LF, et al. Cross-resistance to lincosamides, streptogramins A and pleuromutilins in Streptococcus agalactiae isolates from the USA. J Antimicrob Chemother. 2017;72(7):1886-1892.

Huang L, Fernandes H, Zia H, Tavassoli P, Rennert H, Pisapia D, et al. The cancer precision medicine knowledge base for structured clinical-grade mutations and interpretations. J Am Med Inform Assoc. 2017;24(3):513-519.

Moffitt AB, Ondrejka SL, McKinney M, Rempel RE, Goodlad JR, Teh CH, et al. Enteropathy-associated T cell lymphoma subtypes are characterized by loss of function of SETD2. J Exp Med. 2017;214(5):1371-1386.